Exact Mass: 455.22425080000005

Exact Mass Matches: 455.22425080000005

Found 29 metabolites which its exact mass value is equals to given mass value 455.22425080000005, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Gly His Arg Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C17H29N9O6 (455.2240694)


   

Gly His Ser Arg

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C17H29N9O6 (455.2240694)


   

Gly Arg His Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C17H29N9O6 (455.2240694)


   

Gly Arg Ser His

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H29N9O6 (455.2240694)


   

Gly Ser His Arg

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C17H29N9O6 (455.2240694)


   

Gly Ser Arg His

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H29N9O6 (455.2240694)


   

His Gly Arg Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C17H29N9O6 (455.2240694)


   

His Gly Ser Arg

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C17H29N9O6 (455.2240694)


   

His Arg Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]acetamido}-3-hydroxypropanoic acid

C17H29N9O6 (455.2240694)


   

His Arg Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]acetic acid

C17H29N9O6 (455.2240694)


   

His Ser Gly Arg

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]acetamido}-5-carbamimidamidopentanoic acid

C17H29N9O6 (455.2240694)


   

His Ser Arg Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]acetic acid

C17H29N9O6 (455.2240694)


   

Arg Gly His Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C17H29N9O6 (455.2240694)


   

Arg Gly Ser His

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H29N9O6 (455.2240694)


   

Arg His Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-hydroxypropanoic acid

C17H29N9O6 (455.2240694)


   

Arg His Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]acetic acid

C17H29N9O6 (455.2240694)


   

Arg Ser Gly His

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C17H29N9O6 (455.2240694)


   

Arg Ser His Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C17H29N9O6 (455.2240694)


   

Ser Gly His Arg

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C17H29N9O6 (455.2240694)


   

Ser Gly Arg His

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H29N9O6 (455.2240694)


   

Ser His Gly Arg

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}-5-carbamimidamidopentanoic acid

C17H29N9O6 (455.2240694)


   

Ser His Arg Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]acetic acid

C17H29N9O6 (455.2240694)


   

Ser Arg Gly His

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C17H29N9O6 (455.2240694)


   

Ser Arg His Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C17H29N9O6 (455.2240694)


   

2,6-bis(diphenylmethyl)-4-methoxyaniline

2,6-bis(diphenylmethyl)-4-methoxyaniline

C33H29NO (455.2249024)


   
   

(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N,N-dimethyl-4-[3-[(E)-prop-1-enyl]phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N,N-dimethyl-4-[3-[(E)-prop-1-enyl]phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

C25H33N3O3S (455.22425080000005)


   

CMF019

CMF019

C25H33N3O3S (455.22425080000005)


CMF019 is a potent and small molecule agonist at Apelin receptor (APJ) with G protein bias. CMF019 binds to APJ with pKi values of 8.58, 8.49 and 8.71 for human, rat, and mouse, respectively. CMF019 mimics the beneficial cardiovascular actions of apelin in rodents[1]. Apelin receptor (APJ) is a G protein-coupled receptor (GPCR) activated by the endogenous peptide apelin[2].

   

Diprotin A (TFA)

Diprotin A (TFA)

C19H32F3N3O6 (455.2243088)


Diprotin A TFA (Ile-Pro-Ile TFA) is an inhibitor of dipeptidyl peptidase IV (DPP-IV)[1].